Literature DB >> 21969133

Breast cancer statistics, 2011.

Carol DeSantis1, Rebecca Siegel, Priti Bandi, Ahmedin Jemal.   

Abstract

In this article, the American Cancer Society provides an overview of female breast cancer statistics in the United States, including trends in incidence, mortality, survival, and screening. Approximately 230,480 new cases of invasive breast cancer and 39,520 breast cancer deaths are expected to occur among US women in 2011. Breast cancer incidence rates were stable among all racial/ethnic groups from 2004 to 2008. Breast cancer death rates have been declining since the early 1990s for all women except American Indians/Alaska Natives, among whom rates have remained stable. Disparities in breast cancer death rates are evident by state, socioeconomic status, and race/ethnicity. While significant declines in mortality rates were observed for 36 states and the District of Columbia over the past 10 years, rates for 14 states remained level. Analyses by county-level poverty rates showed that the decrease in mortality rates began later and was slower among women residing in poor areas. As a result, the highest breast cancer death rates shifted from the affluent areas to the poor areas in the early 1990s. Screening rates continue to be lower in poor women compared with non-poor women, despite much progress in increasing mammography utilization. In 2008, 51.4% of poor women had undergone a screening mammogram in the past 2 years compared with 72.8% of non-poor women. Encouraging patients aged 40 years and older to have annual mammography and a clinical breast examination is the single most important step that clinicians can take to reduce suffering and death from breast cancer. Clinicians should also ensure that patients at high risk of breast cancer are identified and offered appropriate screening and follow-up. Continued progress in the control of breast cancer will require sustained and increased efforts to provide high-quality screening, diagnosis, and treatment to all segments of the population.
Copyright © 2011 American Cancer Society, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21969133     DOI: 10.3322/caac.20134

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  417 in total

1.  Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer.

Authors:  Minqing Wu; Weidong Wei; Xiangsheng Xiao; Jiaoli Guo; Xinhua Xie; Laisheng Li; Yanan Kong; Ning Lv; Weihua Jia; Yin Zhang; Xiaoming Xie
Journal:  Med Oncol       Date:  2012-06-04       Impact factor: 3.064

2.  Explaining and improving breast cancer information acquisition among African American women in the Deep South.

Authors:  Charkarra Anderson-Lewis; Levi Ross; Jarrett Johnson; Janice L Hastrup; B Lee Green; Connie L Kohler
Journal:  South Med J       Date:  2012-06       Impact factor: 0.954

Review 3.  Obesity in cancer survival.

Authors:  Niyati Parekh; Urmila Chandran; Elisa V Bandera
Journal:  Annu Rev Nutr       Date:  2012-04-23       Impact factor: 11.848

4.  Challenges in ductal carcinoma in situ risk communication and decision-making: report from an American Cancer Society and National Cancer Institute workshop.

Authors:  Ann H Partridge; Joann G Elmore; Debbie Saslow; Worta McCaskill-Stevens; Stuart J Schnitt
Journal:  CA Cancer J Clin       Date:  2012-04-04       Impact factor: 508.702

5.  68Ga-NOTA-RM26 PET/CT in the Evaluation of Breast Cancer: A Pilot Prospective Study.

Authors:  Jie Zang; Feng Mao; Hao Wang; Jingjing Zhang; Qingxing Liu; Li Peng; Fang Li; Lixin Lang; Xiaoyuan Chen; Zhaohui Zhu
Journal:  Clin Nucl Med       Date:  2018-09       Impact factor: 7.794

6.  Genetic variation in multiple biologic pathways, flavonoid intake, and breast cancer.

Authors:  Nikhil K Khankari; Patrick T Bradshaw; Lauren E McCullough; Susan L Teitelbaum; Susan E Steck; Brian N Fink; Xinran Xu; Jiyoung Ahn; Christine B Ambrosone; Katherine D Crew; Mary Beth Terry; Alfred I Neugut; Jia Chen; Regina M Santella; Marilie D Gammon
Journal:  Cancer Causes Control       Date:  2013-11-27       Impact factor: 2.506

7.  Histone demethylase RBP2 is critical for breast cancer progression and metastasis.

Authors:  Jian Cao; Zongzhi Liu; William K C Cheung; Minghui Zhao; Sophia Y Chen; Siew Wee Chan; Carmen J Booth; Don X Nguyen; Qin Yan
Journal:  Cell Rep       Date:  2014-02-27       Impact factor: 9.423

Review 8.  Second malignancies after breast cancer: The impact of adjuvant therapy.

Authors:  Chunhui Dong; Ling Chen
Journal:  Mol Clin Oncol       Date:  2014-02-03

Review 9.  Gold nanoparticles in breast cancer treatment: promise and potential pitfalls.

Authors:  Jihyoun Lee; Dev Kumar Chatterjee; Min Hyuk Lee; Sunil Krishnan
Journal:  Cancer Lett       Date:  2014-02-17       Impact factor: 8.679

10.  Potential Indexing of the Invasiveness of Breast Cancer Cells by Mitochondrial Redox Ratios.

Authors:  Nannan Sun; He N Xu; Qingming Luo; Lin Z Li
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.